This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jerry B. Vannatta, MD; Robert Whang, MD; Solomon Papper, MD

Arch Intern Med. 1981;141(7):885-887.

Abstract
• To evaluate the efficacy and safety of a simple approach to intravenous (IV) phosphorus therapy, ten adult patients with severe hypophosphatemia ( 1 mg/dL) and normal renal function were studied prospectively. They were treated with a solution containing 9 mmole of phosphorus as monobasic potassium phosphate (KH₂PO₄), infused continuously every 12 hours. Serum phosphorus, potassium, and calcium levels and urinary excretion of phosphorus were measured every 12 hours. The serum phosphorus level was significantly improved at 12 hours, more than 1 mg/dL in all patients at 36 hours, and normal in six patients at 48 hours. The serum potassium level was never above normal, and serum calcium levels declined in only one patient. Administration of 9 mmole of phosphorus as KH₂PO₄ every 12 hours is both safe and efficacious IV therapy for severe hypophosphatemia in the adult patient with normal renal function and without hyperkalemia or hypercalcemia.

(Arch Intern Med 1981;141:885-887)

Author Affiliations
From Presbyterian Hospital (Dr Vannatta), Oklahoma City Veterans Administration Medical Center (Dr Whang), and the Department of Medicine at University Hospital, University of Oklahoma Health Sciences Center (Dr Papper), Oklahoma City.

Footnotes
Accepted for publication May 16, 1980.

Read at the Fourth International Workshop on Phosphorus Metabolism and Other Minerals, Strasbourg, France, June 23, 1979.

Reprint requests to Medical Staff Office, Presbyterian Hospital, NE 13th St at Lincoln Boulevard, Oklahoma City, OK 73104 (Dr Vannatta).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Death Resulting From Overzealous Total Parenteral Nutrition: The Refeeding Syndrome Revisited
Miller
Nutr Clin Pract 2008;23:166-171.
ABSTRACT | FULL TEXT  

A New Graduated Dosing Regimen for Phosphorus Replacement in Patients Receiving Nutrition Support
Brown et al.
JPEN J Parenter Enteral Nutr 2006;30:209-214.
ABSTRACT | FULL TEXT  

Review of the Refeeding Syndrome
Kraft et al.
Nutr Clin Pract 2005;20:625-633.
ABSTRACT | FULL TEXT  

Treatment of electrolyte disorders in adult patients in the intensive care unit
Kraft et al.
Am J Health Syst Pharm 2005;62:1663-1682.
ABSTRACT | FULL TEXT  

Enteral and Parenteral Electrolyte Therapeutics
Baumgartner
Nutr Clin Pract 2001;16:226-232.
 

Hypophosphataemia in anorexia nervosa
Håglin
Postgrad. Med. J. 2001;77:305-311.
FULL TEXT  

Observations of Hypophosphatemia and Its Management in Nutrition Support
Sacks et al.
Nutr Clin Pract 1994;9:105-108.
ABSTRACT  

Severe Hypophosphatemia in Postoperative Patients
Dwyer et al.
Nutr Clin Pract 1992;7:279-283.
ABSTRACT  

Severe Hypophosphatemia Following the Institution of Enteral Feedings
Hayek and Eisenberg
Arch Surg 1989;124:1325-1328.
ABSTRACT